Loading clinical trials...
Loading clinical trials...
International, Multicenter, Prospective Registry to Collect Data of Patients Treated With Alloplastic Total Temporomandibular Joint (TMJ) Replacements
Prospective data will be collected in approximately 200 patients treated with an TMJ replacement. Patients will be followed up according to the standard (routine) for up to 5 years after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s and anticipated or procedure-related adverse events (i.e. complications). This registry is designed to be able to assess the number of patients who refuse alloplastic total TMJ replacement. Therefore, the participating sites are asked to register all cases of refused TMJ replacements too.
More in detail this registry has the following objectives: * To describe clinical indications for TMJ replacement, and treatment patterns (including differences among regions if feasible) * To describe the clinical evolution and outcomes of patients treated with a TMJ replacement * To explore the relationship(s) between treatment, outcome(s) and quality of life (QoL). * To identify predictive factors for favorable outcomes (pain reduction, range of motion (ROM), occlusal status, QoL) in patients treated with TMJ replacement. * To describe the reasons of patients who refused TMJ replacements
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hospital BP - A Beneficência Portuguesa de São Paulo
São Paulo, Brazil
Estetica Maxilofacial
Bogotá, Colombia
Rigshospitalet
Copenhagen, Denmark
Hannover Medical School
Hanover, Germany
University Hospital Leipzig
Leipzig, Germany
Klinikum der Johannes Gutenberg Universität Mainz
Mainz, Germany
Klinikum der LMU München
Munich, Germany
Sri Shankara Cancer Hospital and Research Center
Bangalore, India
All India Institute of Medical Sciences (AIIMS)
New Delhi, India
Erasmus Medisch Centrum
Rotterdam, Netherlands
Start Date
October 15, 2019
Primary Completion Date
September 1, 2032
Completion Date
December 1, 2033
Last Updated
February 18, 2026
200
ESTIMATED participants
Lead Sponsor
AO Innovation Translation Center
NCT07317570
NCT05006963
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06721104